Download PDF

Register to download the report. Already a member?

Sign Up


71729 1526457625HCLS_ECUADOR_Final.pdf
Energy Boardroom

Type your email in the box below to read this content NOW:


Petar Vazharov – Executive Vice President APAC, Alvogen; Jefferson Wang – General Manager, Lotus, Taiwan

12Petar Vazharov, Alvogen’s executive vice president for Asia Pacific, and, Jefferson Wang, general manager of Lotus, provide insights into Lotus’ tremendous evolution from a local generics company into a regional player holding international ambitions, and highlight the main achievements of this fast-growing company since it joined the Alvogen group in 2014.

In 2014, Alvogen became the first foreign company to acquire a majority stake in a Taiwanese pharmaceutical company, while Lotus used the proceeds of the share issue to acquire several of Alvogen's businesses in Asia. Could you briefly explain what was the strategic thinking that motivated this merger?

Petar Vazharov (PV): Alvogen’s fundamental strategy was already defined back in 2009: firstly, aiming to the US market, and, secondly, penetrating emerging markets, namely Central-Eastern Europe (CEE) and Asia Pacific. Acquisitions are a typical method to accelerate commercial success in a given region, allowing ambitious companies like Alvogen to access already-established platforms with strong capabilities in R&D and product manufacturing at local and international levels.



Most Read

Download PDF

First Name:

Last Name: